BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 69 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,118,000 | -4.9% | 62,245 | +16.7% | 3.37% | +296.8% |
| Q3 2019 | $2,226,000 | -22.1% | 53,345 | -18.2% | 0.85% | -9.3% |
| Q2 2019 | $2,857,000 | -27.3% | 65,249 | -14.6% | 0.94% | -8.4% |
| Q1 2019 | $3,931,000 | +0.6% | 76,379 | -27.7% | 1.02% | -20.3% |
| Q4 2018 | $3,909,000 | -1.5% | 105,706 | 0.0% | 1.28% | +46.6% |
| Q3 2018 | $3,969,000 | -5.0% | 105,706 | 0.0% | 0.88% | -2.7% |
| Q2 2018 | $4,178,000 | +53.4% | 105,706 | 0.0% | 0.90% | +51.8% |
| Q1 2018 | $2,723,000 | -4.5% | 105,706 | 0.0% | 0.59% | -25.9% |
| Q4 2017 | $2,852,000 | +280.3% | 105,706 | +252.4% | 0.80% | +226.5% |
| Q2 2017 | $750,000 | – | 30,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 857,494 | $55,746,000 | 45.68% |
| RP Management, LLC | 2,111,111 | $137,243,000 | 20.57% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,074,800 | $134,883,000 | 17.78% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,310,261 | $85,180,000 | 9.56% |
| TANG CAPITAL MANAGEMENT LLC | 599,091 | $38,947,000 | 7.05% |
| Blackcrane Capital, LLC | 44,112 | $2,868,000 | 6.69% |
| ARS Investment Partners, LLC | 559,574 | $36,378,000 | 5.72% |
| Eversept Partners, LP | 321,581 | $20,905,981 | 4.64% |
| Avidity Partners Management LP | 1,284,200 | $83,486,000 | 3.87% |
| ARDSLEY ADVISORY PARTNERS LP | 257,000 | $16,708,000 | 3.22% |